- $1.27bn
- $1.31bn
- $545.53m
- 77
- 36
- 78
- 69
Annual income statement for Xometry, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 141 | 218 | 381 | 463 | 546 |
| Cost of Revenue | |||||
| Gross Profit | 33.3 | 57.1 | 146 | 178 | 216 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 171 | 277 | 458 | 537 | 602 |
| Operating Profit | -29.2 | -59 | -77.1 | -73.6 | -56.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -31.1 | -61.4 | -79 | -67.8 | -50.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -31.1 | -61.4 | -79 | -67.5 | -50.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -31.1 | -61.4 | -79.1 | -67.5 | -50.4 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -39.9 | -61.4 | -79.1 | -67.5 | -50.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.893 | -1.19 | -1.63 | -1.26 | -1.02 |
| Dividends per Share |